RxDoctor Payments Data

Cheryl Jeter

Family · Virginia Beach, VANPI 1801078696

Payments from drug & device makers

$5,667in general payments, 2019–2025

Across 340 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$710
  • Lundbeck LLC$705
  • Lilly USA, LLC$222
  • Amgen$201
  • Vertex$160
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$5,667100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,667 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl46$52,154
Levorphanol Tartrate11$30,570
Buprenorphine112$30,006
Nucynta ErTapentadol Hcl14$26,744
Xtampza ErOxycodone Myristate12$16,723
BelbucaBuprenorphine Hcl31$12,361
Acetaminophen-CodeineAcetaminophen With Codeine231$7,959
Gabapentin280$5,013
Tramadol Hcl450$4,656
Pregabalin95$3,589
Duloxetine Hcl139$3,129
Tramadol Hcl ErTramadol Hcl19$1,942
Codeine Sulfate21$1,132
Chlorzoxazone11$708
Baclofen11$668

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta, Nucynta Er, Xtampza Er, Belbuca$83$107,981103 claims
Virtus Pharmaceuticals LLCLevorphanol Tartrate$74$30,57011 claims
Hikma Pharmaceuticals USABuprenorphine$32$30,006112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.

Other family in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →